AI in Remote Patient Monitoring (RPM) Market - Global Forecast to 2030
商品番号 : SMB-74962
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
| ページ数 | 324 |
| 図表数 | 349 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The AI in remote patient monitoring market is projected to reach USD 8,438.5 million by 2030 from USD 1,967.7 million in 2024, at a high CAGR of 27.5% during the forecast period.
遠隔患者モニタリング（RPM）向けのAI市場は、予測期間中に 27.5% という高い CAGR で成長し、2024 年の 19 億 6,770 万ドルから 2030 年には 84 億 3,850 万ドルに達すると予測されています。
Reason for growth in the AI in remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. According to US CDC about 1 in 31 hospital patients has at least one healthcare-associated infection. For instance, the University of Pittsburgh Medical Center reported that RPM devices reduced hospital readmissions by 76%.
遠隔患者モニタリング市場における AI の成長理由: 血流感染症、尿路感染症、肺炎、クロストリジウム・ディフィシル感染症などの院内感染 (HAI) にかかる人が増えています。これらの感染症は、病院での重大な健康合併症や死亡に関連しているため、リスクの予防と管理には、患者を遠隔でモニタリングするソリューションが必要でした。さらに、心血管疾患、肥満、糖尿病などの慢性疾患の発生率が上昇しており、効果的な遠隔モニタリング技術の需要が高まっています。
米国の医療費は大幅に悪化しており、米国の成人のほぼ半数が処方薬や医師の診察を受けるのに苦労しています。米国 CDC によると、入院患者の約 31 人に 1 人が少なくとも 1 つの医療関連感染症にかかっています。たとえば、ピッツバーグ大学医療センターは、RPM デバイスによって入院再発が 76% 減少したと報告しています。
“Wearable devices is the fastest growing segment in the AI in remote patient monitoring market by devices in 2023”
Wearable devices is expected to be the fastest-growing segment in the AI in remote patient monitoring market during 2023, due to the increasing acceptance of AI-enabled biosensors, smartwatches, and wearables for medical use. These devices are based on machine learning, deep learning, and continuous monitoring of vital signs, early detecting potential health issues, and supplying predictive insights. Other developments in AI-enabled ECG monitoring, glucose monitoring, and telehealth-enabling wearables are further supporting growth by increasing patient engagement and chronic disease management. For instance, in August 2024, Masimo’s W1 Medical Watch received FDA 510(k) clearance to be incorporated into the Masimo SafetyNet Telemonitoring System for remote monitoring of health in real-time.
“North America dominated the remote patient monitoring market in 2023.”
The AI in remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region’s market. As of 2023, over 500 medical AI devices have undergone U.S. Food and Drug Administration (FDA) evaluation and received approval including RPM related medical devices.
The break-down of primary participants is as mentioned below:
- By Company Type – Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
- By Designation – C-level: 35%, Director-level: 40%, and Others: 25%
- By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE HealthCare (US), Medtronic (Ireland), AliveCor, Inc. (US), NIHON KOHDEN CORPORATION (Japan), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), Beijing Choice Electronic Tech Co. Ltd (US), Biobeat (Israel), Biotronik (Germany), and AccurKardia, Inc. (US) are some of the key players in the AI in remote patient monitoring market.
The study includes an in-depth competitive analysis of these key players in the AI in remote patient monitoring market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the AI in remote patient monitoring market by component (devices [wearable devices, implantable devices, handheld & portable devices, stationary devices]), software and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and other indications (obstetrics, immunology, infectious diseases, ophthalmology, and others). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the AI in remote patient monitoring market. Competitive analysis of upcoming startups in the AI in remote patient monitoring market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the AI in remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (growing telehealth and remote patient monitoring markets, rising prevalence of chronic diseases, growing adoption of mhealth apps, increased government support and favorable reimbursement policies, growing awareness about lifestyle management and home healthcare) restraints (regulatory variations across regions, shortage of skilled professionals to operate AI based tools, and data security concerns) opportunities (growing in the demand for personalized medicine, increase in the partnership and collaboration among healthcare providers and AI based companies, growing opportunities in emerging nations, hospital-at-home, and rising investment in AI based RPM solutions) challenges (issues related to accuracy due to scarcity of high quality healthcare data, reluctance among healthcare professionals to adopt AI in remote patient monitoring, and lack of interoperability)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in remote patient monitoring market
- Market Development: Comprehensive information about lucrative markets – the report analyses the AI in remote patient monitoring market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in remote patient monitoring market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthare, Inc. (Japan), GE HealthCare (US), Boston Scientific Corporation (US), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), NIHON KOHDEN CORPORATION (Japan), and Biotronik (Germany); among others in the AI in remote patient monitoring market
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 30
1.3.2 INCLUSIONS & EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 32
1.3.4 CURRENCY CONSIDERED 32
1.4 STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key sources of secondary data 35
2.1.1.2 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Key sources of primary data 36
2.1.2.2 Objectives of primary research 36
2.1.2.3 Key data from primary sources 37
2.1.2.4 Key insights from primary experts 38
2.1.2.5 Breakdown of primary sources 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 SUPPLY-SIDE ANALYSIS 41
2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 43
2.2.3 TOP-DOWN APPROACH 44
2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 44
2.3 DATA TRIANGULATION 48
2.4 STUDY ASSUMPTIONS 49
2.4.1 MARKET SIZING ASSUMPTIONS 49
2.4.2 MARKET GROWTH ASSUMPTIONS 49
2.5 RISK ANALYSIS 50
2.6 RESEARCH LIMITATIONS 50
2.6.1 METHODOLOGY-RELATED LIMITATIONS 50
2.6.2 SCOPE-RELATED LIMITATIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 55
4.1 AI IN REMOTE PATIENT MONITORING MARKET OVERVIEW 55
4.2 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER AND REGION, 2023 56
4.3 AI IN REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT 57
4.4 AI IN REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 60
5.2.1.1 Expanding telehealth and remote patient monitoring markets 60
5.2.1.2 Increasing prevalence of chronic diseases 61
5.2.1.3 Focus on development and adoption of mHealth applications 61
5.2.1.4 Increased government support and favorable reimbursement policies 62
5.2.1.5 Growing awareness about lifestyle management and home healthcare 62
5.2.2 RESTRAINTS 63
5.2.2.1 Regulatory variations across regions 63
5.2.2.2 Shortage of skilled professionals to operate AI-based remote patient monitoring tools 63
5.2.2.3 Data security concerns 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Growing demand for personalized medicines and care plans 64
5.2.3.2 Increase in partnerships and collaborations among healthcare providers and AI-based companies 65
5.2.3.3 Growth opportunities in emerging economies 66
5.2.3.4 Rising investment in AI-based remote patient monitoring solutions 66
5.2.4 CHALLENGES 67
5.2.4.1 Scarcity of high-quality healthcare data and privacy concerns 67
5.2.4.2 Reluctance among healthcare professionals to adopt AI in remote patient monitoring devices 67
5.2.4.3 Lack of interoperability 68
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 68
5.4 INDUSTRY TRENDS 69
5.4.1 SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 69
5.4.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES 69
5.5 ECOSYSTEM ANALYSIS 69
5.5.1 ROLE IN ECOSYSTEM 71
5.6 VALUE CHAIN ANALYSIS 72
5.7 TECHNOLOGY ANALYSIS 73
5.7.1 KEY TECHNOLOGIES 73
5.7.1.1 Wearable devices and sensors 73
5.7.1.2 AI and ML 73
5.7.1.3 Predictive analytics 74
5.7.2 COMPLEMENTARY TECHNOLOGIES 74
5.7.2.1 mHealth applications 74
5.7.2.2 Cloud computing 74
5.7.2.3 Digital health platforms 75
5.7.3 ADJACENT TECHNOLOGIES 75
5.7.3.1 Point-of-care diagnostics 75
5.7.3.2 Smart home health devices 75
5.8 TARIFF & REGULATORY ANALYSIS 76
5.8.1 TARIFF ANALYSIS 76
5.8.1.1 Tariff data for HS code 9018 76
5.8.1.2 Tariff data for HS code 9021 77
5.8.1.3 Tariff data for HS code 9022 78
5.8.2 REGULATORY FRAMEWORK 79
5.8.2.1 North America 79
5.8.2.2 Europe 80
5.8.2.3 Asia Pacific 81
5.8.2.4 Middle East & Africa 82
5.8.2.5 Latin America 82
5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
5.9 TRADE ANALYSIS 87
5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099 87
5.9.1.1 Import data for HSN code 90189099 88
5.9.1.2 Export data for HSN code 90189099 88
5.9.2 TRADE ANALYSIS FOR HSN CODE 9021 89
5.9.2.1 Import data for HSN code 9021 89
5.9.2.2 Export data for HSN code 9021 89
5.9.3 TRADE ANALYSIS FOR HSN CODE 9022 90
5.9.3.1 Import data for HSN code 9022 90
5.9.3.2 Export data for HSN code 9022 90
5.10 PRICING ANALYSIS 91
5.10.1 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023 91
5.10.2 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 92
5.11 PORTER’S FIVE FORCES ANALYSIS 93
5.11.1 INTENSITY OF COMPETITIVE RIVALRY 95
5.11.2 BARGAINING POWER OF BUYERS 95
5.11.3 THREAT OF SUBSTITUTES 95
5.11.4 THREAT OF NEW ENTRANTS 95
5.11.5 BARGAINING POWER OF SUPPLIERS 95
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.12.2 KEY BUYING CRITERIA 97
5.13 PATENT ANALYSIS 97
5.13.1 PATENT PUBLICATION TRENDS 97
5.13.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 98
5.13.3 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET 99
5.13.4 LIST OF KEY PATENTS/PATENT APPLICATIONS 100
5.14 UNMET NEEDS & END-USER EXPECTATIONS 102
5.14.1 UNMET NEEDS 102
5.14.2 END-USER EXPECTATIONS 103
5.15 KEY CONFERENCES & EVENTS, 2025–2026 104
5.16 CASE STUDY ANALYSIS 105
5.16.1 ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING 105
5.16.2 ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS 105
5.16.3 ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY 106
5.17 INVESTMENT & FUNDING SCENARIO 107
5.18 BUSINESS MODEL ANALYSIS 107
5.18.1 SUBSCRIPTION-BASED MODELS 107
5.18.2 PLATFORM-AS-A-SERVICE MODELS 107
5.18.3 SERVICE-BASED MODELS 107
5.18.4 FREEMIUM MODELS 107
5.18.5 COLLABORATIVE ECOSYSTEM AND PARTNERSHIP MODELS 108
5.19 REIMBURSEMENT SCENARIO ANALYSIS 108
6 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT 111
6.1 INTRODUCTION 112
6.2 DEVICES 112
6.2.1 WEARABLE DEVICES 114
6.2.1.1 Rising adoption of consumer health technologies and growing trend toward preventive healthcare to drive segment 114
6.2.2 IMPLANTABLE DEVICES 115
6.2.2.1 Development of wireless communication technologies and advancements in medical devices to spur market adoption 115
6.2.3 HANDHELD & PORTABLE DEVICES 116
6.2.3.1 Rising consumer preference for home healthcare and self-monitoring to aid market growth 116
6.2.4 STATIONARY DEVICES 117
6.2.4.1 Reduced hospitalizations and improved patient outcomes through timely alerts to aid market growth 117
6.3 SOFTWARE 118
6.3.1 EFFECTIVE TRANSFORMATION OF RAW DATA TO PERSONALIZED INSIGHTS FOR PATIENTS TO AUGMENT MARKET GROWTH 118
6.4 SERVICES 119
6.4.1 INCREASING NEED FOR VALUE-BASED SPECIALIZED SERVICES TO BOOST MARKET GROWTH 119
7 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION 121
7.1 INTRODUCTION 122
7.2 ONCOLOGY 122
7.2.1 NEED FOR IMPROVED SYMPTOM MONITORING AND PERSONALIZED TREATMENT PLANS TO DRIVE MARKET 122
7.3 CARDIOLOGY 124
7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH 124
7.4 NEUROLOGY 124
7.4.1 GROWING ADOPTION OF TELEMEDICINE AND RISING NEED FOR CONTINUOUS MONITORING TO AID MARKET GROWTH 124
7.5 DIABETES 125
7.5.1 HIGH ADOPTION OF AI-POWERED DEVICES FOR EFFECTIVE DIABETES MANAGEMENT TO PROPEL MARKET GROWTH 125
7.6 SLEEP DISORDERS 126
7.6.1 AI-POWERED REMOTE PATIENT MONITORING DEVICES TO ENSURE EFFECTIVE SLEEP APNEA MANAGEMENT 126
7.7 RESPIRATORY DISEASES 127
7.7.1 GROWING BURDEN OF COPD AND ASTHMA IN LOW- AND MIDDLE-INCOME COUNTRIES TO SUPPORT MARKET GROWTH 127
7.8 WELLNESS IMPROVEMENT 128
7.8.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISEASES TO AUGMENT MARKET GROWTH 128
7.9 MENTAL HEALTH DISORDERS 129
7.9.1 AI-BASED REMOTE PATIENT MONITORING TO IMPROVE ACCESS TO MENTAL HEALTH SUPPORT AND REDUCE STIGMA OF IN-PERSON THERAPY 129
7.10 OTHER INDICATIONS 129
8 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER 131
8.1 INTRODUCTION 132
8.2 HEALTHCARE PROVIDERS 132
8.2.1 HOSPITALS 134
8.2.1.1 Rising demand for high-quality care and increasing incidence of chronic diseases to drive market 134
8.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 135
8.2.2.1 AI-driven remote patient monitoring devices to enhance postoperative care, patient safety, and recovery outcomes 135
8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 135
8.2.3.1 Need for prolonged treatment for chronic diseases and high cost of hospital stays to fuel uptake 135
8.2.4 HOME HEALTHCARE FACILITIES 136
8.2.4.1 Increased preference for at-home treatment options to drive market 136
8.2.5 OTHER HEALTHCARE PROVIDERS 137
8.3 HEALTHCARE PAYERS 138
8.3.1 FAVORABLE REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING SERVICES TO AUGMENT MARKET GROWTH 138
8.4 PATIENTS 138
8.4.1 ADVANCEMENTS IN WEARABLE DEVICES AND PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH 138
8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 139
8.5.1 AI-BASED REMOTE PATIENT MONITORING SOLUTIONS TO ASSIST PHARMA COMPANIES EXPAND MARKET PRESENCE 139
8.6 MEDTECH COMPANIES 140
8.6.1 RISING DEMAND FOR ADVANCED TECHNOLOGIES FOR REMOTE DISEASE DIAGNOSIS AND TREATMENT TO FAVOR MARKET GROWTH 140
8.7 OTHER END USERS 141
9 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION 142
9.1 INTRODUCTION 143
9.2 NORTH AMERICA 144
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 145
9.2.2 US 148
9.2.2.1 US to dominate North American market during study period 148
9.2.3 CANADA 151
9.2.3.1 Need to curtail healthcare costs and high penetration of smartphones and tablets to drive market 151
9.3 EUROPE 154
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154
9.3.2 GERMANY 157
9.3.2.1 High healthcare expenditure and increased preference for home monitoring to propel market growth 157
9.3.3 UK 160
9.3.3.1 Favorable government initiatives and high demand for advanced healthcare solutions to aid market growth 160
9.3.4 FRANCE 163
9.3.4.1 Increased adoption of connected medical devices to fuel market growth 163
9.3.5 ITALY 166
9.3.5.1 Increased government health expenditure and high geriatric population to boost market growth 166
9.3.6 SPAIN 169
9.3.6.1 Need to reduce healthcare costs and improve treatment quality to drive adoption of AI-based remote patient monitoring devices 169
9.3.7 REST OF EUROPE 172
9.4 ASIA PACIFIC 175
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 176
9.4.2 CHINA 180
9.4.2.1 Strong internet access and high smartphone adoption to augment market growth 180
9.4.3 JAPAN 183
9.4.3.1 Rising geriatric population and increasing government health expenditure to aid market growth 183
9.4.4 INDIA 186
9.4.4.1 Need to bridge gap between rural patients and urban doctors to propel market growth 186
9.4.5 REST OF ASIA PACIFIC 189
9.5 LATIN AMERICA 191
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 191
9.5.2 BRAZIL 194
9.5.2.1 Favorable government initiatives and increased health expenditure to favor market growth 194
9.5.3 MEXICO 197
9.5.3.1 Technological advancements and favorable legal policies for digital health technologies to drive market 197
9.5.4 REST OF LATIN AMERICA 200
9.6 MIDDLE EAST & AFRICA 203
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 203
9.6.2 GCC COUNTRIES 206
9.6.2.1 Favorable government and non-government initiatives and increased investment in healthcare infrastructure to drive market 206
9.6.3 REST OF MIDDLE EAST & AFRICA 209
10 COMPETITIVE LANDSCAPE 213
10.1 INTRODUCTION 213
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN REMOTE PATIENT MONITORING MARKET 214
10.3 REVENUE ANALYSIS, 2019–2023 216
10.4 MARKET SHARE ANALYSIS, 2023 217
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 220
10.5.1 STARS 220
10.5.2 EMERGING LEADERS 220
10.5.3 PERVASIVE PLAYERS 220
10.5.4 PARTICIPANTS 220
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 222
10.5.5.1 Company footprint 222
10.5.5.2 Region footprint 223
10.5.5.3 Component footprint 224
10.5.5.4 Indication footprint 225
10.5.5.5 End-user footprint 226
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 227
10.6.1 PROGRESSIVE COMPANIES 227
10.6.2 RESPONSIVE COMPANIES 227
10.6.3 DYNAMIC COMPANIES 227
10.6.4 STARTING BLOCKS 227
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 229
10.6.5.1 Detailed list of key startups/SMEs 229
10.6.5.2 Competitive benchmarking of key emerging players/startups 229
10.7 COMPANY VALUATION & FINANCIAL METRICS 230
10.7.1 FINANCIAL METRICS 230
10.7.2 COMPANY VALUATION 230
10.8 BRAND/SOFTWARE COMPARISON 231
10.9 COMPETITIVE SCENARIO 232
10.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 232
10.9.2 DEALS 233
10.9.3 EXPANSIONS 234
10.9.4 OTHER DEVELOPMENTS 234
11 COMPANY PROFILES 235
11.1 KEY PLAYERS 235
11.1.1 MEDTRONIC 235
11.1.1.1 Business overview 235
11.1.1.2 Products/Services/Solutions offered 236
11.1.1.3 Recent developments 238
11.1.1.3.1 Product approvals 238
11.1.1.3.2 Deals 238
11.1.1.4 MnM view 239
11.1.1.4.1 Right to win 239
11.1.1.4.2 Strategic choices 239
11.1.1.4.3 Weaknesses & competitive threats 239
11.1.2 KONINKLIJKE PHILIPS N.V. 240
11.1.2.1 Business overview 240
11.1.2.2 Products/Services/Solutions offered 241
11.1.2.3 Recent developments 243
11.1.2.3.1 Product launches & approvals 243
11.1.2.3.2 Deals 244
11.1.2.4 MnM view 246
11.1.2.4.1 Right to win 246
11.1.2.4.2 Strategic choices 246
11.1.2.4.3 Weaknesses & competitive threats 246
11.1.3 GE HEALTHCARE 247
11.1.3.1 Business overview 247
11.1.3.2 Products/Services/Solutions offered 248
11.1.3.3 Recent developments 249
11.1.3.3.1 Deals 249
11.1.3.4 MnM view 250
11.1.3.4.1 Right to win 250
11.1.3.4.2 Strategic choices 250
11.1.3.4.3 Weaknesses & competitive threats 250
11.1.4 BOSTON SCIENTIFIC CORPORATION 251
11.1.4.1 Business overview 251
11.1.4.2 Products/Services/Solutions offered 252
11.1.4.3 Recent developments 253
11.1.4.3.1 Product launches 253
11.1.4.3.2 Deals 254
11.1.4.3.3 Expansions 254
11.1.4.3.4 Other developments 255
11.1.4.4 MnM view 255
11.1.4.4.1 Right to win 255
11.1.4.4.2 Strategic choices 255
11.1.4.4.3 Weaknesses & competitive threats 255
11.1.5 OMRON HEALTHCARE, INC. 256
11.1.5.1 Business overview 256
11.1.5.2 Products/Services/Solutions offered 257
11.1.5.3 Recent developments 259
11.1.5.3.1 Product approvals & enhancements 259
11.1.5.3.2 Deals 259
11.1.5.4 MnM view 260
11.1.5.4.1 Right to win 260
11.1.5.4.2 Strategic choices 260
11.1.5.4.3 Weaknesses & competitive threats 260
11.1.6 RESMED, INC. 261
11.1.6.1 Business overview 261
11.1.6.2 Products/Services/Solutions offered 262
11.1.6.3 Recent developments 264
11.1.6.3.1 Product launches & enhancements 264
11.1.6.3.2 Deals 265
11.1.6.3.3 Expansions 265
11.1.6.3.4 Other developments 266
11.1.7 NIHON KOHDEN CORPORATION 267
11.1.7.1 Business overview 267
11.1.7.2 Products/Services/Solutions offered 268
11.1.7.3 Recent developments 271
11.1.7.3.1 Product launches & approvals 271
11.1.7.3.2 Deals 272
11.1.7.3.3 Other developments 272
11.1.8 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS) 273
11.1.8.1 Business overview 273
11.1.8.2 Products/Services/Solutions offered 274
11.1.8.3 Recent developments 275
11.1.8.3.1 Product launches & approvals 275
11.1.8.3.2 Deals 276
11.1.9 IRHYTHM INC. 277
11.1.9.1 Business overview 277
11.1.9.2 Products/Services/Solutions offered 278
11.1.9.3 Recent developments 279
11.1.9.3.1 Product launches & approvals 279
11.1.9.3.2 Deals 280
11.1.10 BEIJING CHOICE ELECTRONIC TECH CO., LTD. 281
11.1.10.1 Business overview 281
11.1.10.2 Products/Services/Solutions offered 281
11.1.11 BIOTRONIK 283
11.1.11.1 Business overview 283
11.1.11.2 Products/Services/Solutions offered 283
11.1.11.3 Recent developments 284
11.1.11.3.1 Product launches & approvals 284
11.1.11.3.2 Deals 284
11.1.12 ALIVECOR, INC. 285
11.1.12.1 Business overview 285
11.1.12.2 Products/Services/Solutions offered 285
11.1.12.3 Recent developments 286
11.1.12.3.1 Product launches & approvals 286
11.1.12.3.2 Deals 287
11.1.12.3.3 Other developments 288
11.1.13 MASIMO 289
11.1.13.1 Business overview 289
11.1.13.2 Products/Services/Solutions offered 290
11.1.13.3 Recent developments 291
11.1.13.3.1 Product approvals & enhancements 291
11.1.13.4 Recent developments 292
11.1.13.4.1 Deals 292
11.1.14 DEXCOM, INC. 293
11.1.14.1 Business overview 293
11.1.14.2 Products/Services/Solutions offered 294
11.1.14.3 Recent developments 295
11.1.14.3.1 Product launches & approvals 295
11.1.14.3.2 Deals 296
11.1.15 BIOBEAT 297
11.1.15.1 Business overview 297
11.1.15.2 Products/Services/Solutions offered 297
11.1.15.3 Recent developments 298
11.1.15.3.1 Product launches & approvals 298
11.1.15.3.2 Deals 299
11.1.16 TYTOCARE LTD. 301
11.1.16.1 Business overview 301
11.1.16.2 Products/Services/Solutions offered 301
11.1.16.3 Recent developments 302
11.1.16.3.1 Product enhancements 302
11.1.16.3.2 Deals 302
11.1.16.3.3 Other developments 302
11.1.17 ZETO INC. 303
11.1.17.1 Business overview 303
11.1.17.2 Products/Services/Solutions offered 303
11.1.18 GLOOKO, INC. 304
11.1.18.1 Business overview 304
11.1.18.2 Products/Services/Solutions offered 304
11.1.18.3 Recent developments 305
11.1.18.3.1 Product launches & enhancements 305
11.1.18.3.2 Deals 305
11.1.18.3.3 Other developments 306
11.1.19 WELLDOC, INC. 307
11.1.19.1 Business overview 307
11.1.19.2 Products/Services/Solutions offered 307
11.1.19.3 Recent developments 308
11.1.19.3.1 Product approvals & enhancements 308
11.1.19.3.2 Deals 308
11.1.20 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE) 310
11.1.20.1 Business overview 310
11.1.20.2 Products/Services/Solutions offered 310
11.1.20.3 Recent developments 311
11.1.20.3.1 Product approvals 311
11.1.20.3.2 Other developments 311
11.2 OTHER PLAYERS 312
11.2.1 BIOINTELLISENSE, INC. 312
11.2.2 BLUE SPARK TECHNOLOGIES, INC. 313
11.2.3 ACCURKARDIA, INC. 314
11.2.4 AION BIOSYSTEMS, INC. 314
11.2.5 BROOK INC. 315
12 APPENDIX 316
12.1 DISCUSSION GUIDE 316
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 320
12.3 CUSTOMIZATION OPTIONS 322
12.4 RELATED REPORTS 322
12.5 AUTHOR DETAILS 323
LIST OF TABLES
TABLE 1 AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS 31
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32
TABLE 3 AI IN REMOTE PATIENT MONITORING MARKET: FACTOR ANALYSIS 45
TABLE 4 AI IN REMOTE PATIENT MONITORING MARKET: MARKET SIZING ASSUMPTIONS 49
TABLE 5 AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT 50
TABLE 6 AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
TABLE 7 RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022–DECEMBER 2024 60
TABLE 8 AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM 71
TABLE 9 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9018 76
TABLE 10 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9021 77
TABLE 11 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9022 78
TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA 79
TABLE 13 REGULATORY SCENARIO OF EUROPE 80
TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC 81
TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 82
TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA 82
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY,
2019–2023 (USD THOUSAND) 88
TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY,
2019–2023 (USD THOUSAND) 88
TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY,
2019–2023 (USD THOUSAND) 89
TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY,
2019–2023 (USD THOUSAND) 89
TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY,
2019–2023 (USD THOUSAND) 90
TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY,
2019–2023 (USD THOUSAND) 90
TABLE 28 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES,
BY KEY PLAYER, 2023 91
TABLE 29 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES,
BY REGION, 2023 93
TABLE 30 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES 94
TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP
THREE END USERS (%) 96
TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 97
TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 98
TABLE 34 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS 100
TABLE 35 AI IN REMOTE PATIENT MONITORING MARKET: UNMET NEEDS 102
TABLE 36 AI IN REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS 103
TABLE 37 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 104
TABLE 38 CASE STUDY 1: ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING 105
TABLE 39 CASE STUDY 2: ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS 105
TABLE 40 CASE STUDY 2: ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY 106
TABLE 41 CPT CODES AND REIMBURSEMENT ANALYSIS FOR AI-BASED REMOTE PATIENT MONITORING DEVICES IN US 109
TABLE 42 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 112
TABLE 43 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 113
TABLE 44 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 113
TABLE 45 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (THOUSAND UNITS) 114
TABLE 46 AI IN REMOTE PATIENT MONITORING WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 115
TABLE 47 AI IN REMOTE PATIENT MONITORING IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 116
TABLE 48 AI IN REMOTE PATIENT MONITORING HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 117
TABLE 49 AI IN REMOTE PATIENT MONITORING STATIONARY DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 118
TABLE 50 AI IN REMOTE PATIENT MONITORING SOFTWARE MARKET, BY REGION,
2022–2030 (USD MILLION) 119
TABLE 51 AI IN REMOTE PATIENT MONITORING SERVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 120
TABLE 52 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 122
TABLE 53 AI IN REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION,
2022–2030 (USD MILLION) 123
TABLE 54 AI IN REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION) 124
TABLE 55 AI IN REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION) 125
TABLE 56 AI IN REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION,
2022–2030 (USD MILLION) 126
TABLE 57 AI IN REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS,
BY REGION, 2022–2030 (USD MILLION) 127
TABLE 58 AI IN REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES,
BY REGION, 2022–2030 (USD MILLION) 128
TABLE 59 AI IN REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT,
BY REGION, 2022–2030 (USD MILLION) 128
TABLE 60 AI IN REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2022–2030 (USD MILLION) 129
TABLE 61 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS,
BY REGION, 2022–2030 (USD MILLION) 130
TABLE 62 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 132
TABLE 63 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022–2030 (USD MILLION) 133
TABLE 64 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2022–2030 (USD MILLION) 133
TABLE 65 AI IN REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION,
2022–2030 (USD MILLION) 134
TABLE 66 AI IN REMOTE PATIENT MONITORING MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS,
BY REGION, 2022–2030 (USD MILLION) 135
TABLE 67 AI IN REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION) 136
TABLE 68 AI IN REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE FACILITIES, BY REGION, 2022–2030 (USD MILLION) 137
TABLE 69 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 137
TABLE 70 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS,
BY REGION, 2022–2030 (USD MILLION) 138
TABLE 71 AI IN REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION,
2022–2030 (USD MILLION) 139
TABLE 72 AI IN REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 73 AI IN REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES,
BY REGION, 2022–2030 (USD MILLION) 141
TABLE 74 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS,
BY REGION, 2022–2030 (USD MILLION) 141
TABLE 75 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION,
2022–2030 (USD MILLION) 143
TABLE 76 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 145
TABLE 77 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 145
TABLE 78 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 146
TABLE 79 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 146
TABLE 80 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 147
TABLE 81 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 147
TABLE 82 US: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 148
TABLE 83 US: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 149
TABLE 84 US: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 149
TABLE 85 US: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 150
TABLE 86 US: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 150
TABLE 87 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 151
TABLE 88 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 152
TABLE 89 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY INDICATION, 2022–2030 (USD MILLION) 152
TABLE 90 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 153
TABLE 91 CANADA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 92 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 154
TABLE 93 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 155
TABLE 94 EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 155
TABLE 95 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 156
TABLE 96 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 156
TABLE 97 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 157
TABLE 98 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 158
TABLE 99 GERMANY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 158
TABLE 100 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 159
TABLE 101 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 159
TABLE 102 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 160
TABLE 103 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 161
TABLE 104 UK: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 161
TABLE 105 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 162
TABLE 106 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 162
TABLE 107 UK: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 163
TABLE 108 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 164
TABLE 109 FRANCE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 164
TABLE 110 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 165
TABLE 111 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 165
TABLE 112 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 166
TABLE 113 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 167
TABLE 114 ITALY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 167
TABLE 115 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 168
TABLE 116 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 168
TABLE 117 ITALY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 169
TABLE 118 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 170
TABLE 119 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 170
TABLE 120 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 171
TABLE 121 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 171
TABLE 122 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 172
TABLE 123 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 173
TABLE 124 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 173
TABLE 125 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 174
TABLE 126 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 174
TABLE 127 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 175
TABLE 128 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 177
TABLE 129 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 177
TABLE 130 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 178
TABLE 131 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 178
TABLE 132 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 179
TABLE 133 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 179
TABLE 134 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 180
TABLE 135 CHINA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 181
TABLE 136 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 181
TABLE 137 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 182
TABLE 138 CHINA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 182
TABLE 139 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 183
TABLE 140 JAPAN: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 184
TABLE 141 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 184
TABLE 142 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 185
TABLE 143 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 185
TABLE 144 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 186
TABLE 145 INDIA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 187
TABLE 146 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 187
TABLE 147 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 188
TABLE 148 INDIA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 149 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 189
TABLE 150 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 189
TABLE 151 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET,
BY INDICATION, 2022–2030 (USD MILLION) 190
TABLE 152 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET,
BY END USER, 2022–2030 (USD MILLION) 190
TABLE 153 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 154 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 192
TABLE 155 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 192
TABLE 156 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 192
TABLE 157 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 193
TABLE 158 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 193
TABLE 159 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 194
TABLE 160 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 194
TABLE 161 BRAZIL: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 195
TABLE 162 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 195
TABLE 163 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 196
TABLE 164 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 165 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 197
TABLE 166 MEXICO: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 167 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2022–2030 (USD MILLION) 198
TABLE 168 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2022–2030 (USD MILLION) 199
TABLE 169 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 199
TABLE 170 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 200
TABLE 171 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 172 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY INDICATION, 2022–2030 (USD MILLION) 201
TABLE 173 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY END USER, 2022–2030 (USD MILLION) 202
TABLE 174 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 202
TABLE 175 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY REGION, 2022–2030 (USD MILLION) 204
TABLE 176 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 204
TABLE 177 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 178 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY INDICATION, 2022–2030 (USD MILLION) 205
TABLE 179 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET,
BY END USER, 2022–2030 (USD MILLION) 205
TABLE 180 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 206
TABLE 181 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 207
TABLE 182 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 207
TABLE 183 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 208
TABLE 184 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 208
TABLE 185 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 209
TABLE 186 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 210
TABLE 187 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 210
TABLE 188 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION) 211
TABLE 189 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION) 211
TABLE 190 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 212
TABLE 191 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025 214
TABLE 192 AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION 218
TABLE 193 AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT 223
TABLE 194 AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT 224
TABLE 195 AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT 225
TABLE 196 AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 226
TABLE 197 AI IN REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 229
TABLE 198 AI IN REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 229
TABLE 199 AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–JANUARY 2025 232
TABLE 200 AI IN REMOTE PATIENT MONITORING MARKET: DEALS,
JANUARY 2021–JANUARY 2025 233
TABLE 201 AI IN REMOTE PATIENT MONITORING MARKET: EXPANSIONS,
JANUARY 2021–JANUARY 2025 234
TABLE 202 AI IN REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 234
TABLE 203 MEDTRONIC: COMPANY OVERVIEW 235
TABLE 204 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 236
TABLE 205 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 238
TABLE 206 MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025 238
TABLE 207 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 240
TABLE 208 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 241
TABLE 209 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 243
TABLE 210 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025 244
TABLE 211 GE HEALTHCARE: COMPANY OVERVIEW 247
TABLE 212 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 248
TABLE 213 GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025 249
TABLE 214 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 251
TABLE 215 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 252
TABLE 216 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021–JANUARY 2025 253
TABLE 217 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 254
TABLE 218 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025 254
TABLE 219 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 255
TABLE 220 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 256
TABLE 221 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 257
TABLE 222 OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021–JANUARY 2025 259
TABLE 223 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021–JANUARY 2025 259
TABLE 224 RESMED, INC.: COMPANY OVERVIEW 261
TABLE 225 RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 262
TABLE 226 RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–JANUARY 2025 264
TABLE 227 RESMED, INC.: DEALS, JANUARY 2021–JANUARY 2025 265
TABLE 228 RESMED, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 265
TABLE 229 RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 266
TABLE 230 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 267
TABLE 231 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 268
TABLE 232 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 271
TABLE 233 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 272
TABLE 234 NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 272
TABLE 235 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW 273
TABLE 236 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED 274
TABLE 237 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 275
TABLE 238 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): DEALS,
JANUARY 2021–JANUARY 2025 276
TABLE 239 IRHYTHM INC.: COMPANY OVERVIEW 277
TABLE 240 IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 278
TABLE 241 IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 279
TABLE 242 IRHYTHM INC.: DEALS, JANUARY 2021–JANUARY 2025 280
TABLE 243 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW 281
TABLE 244 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 281
TABLE 245 BIOTRONIK: COMPANY OVERVIEW 283
TABLE 246 BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED 283
TABLE 247 BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 284
TABLE 248 BIOTRONIK: DEALS, JANUARY 2021–JANUARY 2025 284
TABLE 249 ALIVECOR, INC.: COMPANY OVERVIEW 285
TABLE 250 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 285
TABLE 251 ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 286
TABLE 252 ALIVECOR, INC.: DEALS, JANUARY 2021–JANUARY 2025 287
TABLE 253 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 288
TABLE 254 MASIMO: COMPANY OVERVIEW 289
TABLE 255 MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED 290
TABLE 256 MASIMO: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021–JANUARY 2025 291
TABLE 257 MASIMO: DEALS, JANUARY 2021–JANUARY 2025 292
TABLE 258 DEXCOM, INC.: COMPANY OVERVIEW 293
TABLE 259 DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 294
TABLE 260 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 295
TABLE 261 DEXCOM, INC.: DEALS, JANUARY 2021–JANUARY 2025 296
TABLE 262 BIOBEAT: COMPANY OVERVIEW 297
TABLE 263 BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 297
TABLE 264 BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 298
TABLE 265 BIOBEAT: DEALS, JANUARY 2021–JANUARY 2025 299
TABLE 266 TYTOCARE LTD.: COMPANY OVERVIEW 301
TABLE 267 TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 301
TABLE 268 TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 302
TABLE 269 TYTOCARE LTD.: DEALS, JANUARY 2021–JANUARY 2025 302
TABLE 270 TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 302
TABLE 271 ZETO INC.: COMPANY OVERVIEW 303
TABLE 272 ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 303
TABLE 273 GLOOKO, INC.: COMPANY OVERVIEW 304
TABLE 274 GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 304
TABLE 275 GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–JANUARY 2025 305
TABLE 276 GLOOKO, INC.: DEALS, JANUARY 2021–JANUARY 2025 305
TABLE 277 GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 306
TABLE 278 WELLDOC, INC.: COMPANY OVERVIEW 307
TABLE 279 WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 307
TABLE 280 WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021–JANUARY 2025 308
TABLE 281 WELLDOC, INC.: DEALS, JANUARY 2021–JANUARY 2025 308
TABLE 282 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW 310
TABLE 283 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCTS/SERVICES/ SOLUTIONS OFFERED 310
TABLE 284 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 311
TABLE 285 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 311
TABLE 286 BIOINTELLISENSE, INC.: COMPANY OVERVIEW 312
TABLE 287 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW 313
TABLE 288 ACCURKARDIA, INC.: COMPANY OVERVIEW 314
TABLE 289 AION BIOSYSTEMS, INC.: COMPANY OVERVIEW 314
TABLE 290 BROOK INC.: COMPANY OVERVIEW 315
LIST OF FIGURES
FIGURE 1 AI IN REMOTE PATIENT MONITORING MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 30
FIGURE 2 AI IN REMOTE PATIENT MONITORING MARKET: YEARS CONSIDERED 32
FIGURE 3 AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN 34
FIGURE 4 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM SECONDARY SOURCES 35
FIGURE 5 AI IN REMOTE PATIENT MONITORING MARKET: KEY PRIMARY SOURCES 36
FIGURE 6 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM PRIMARY SOURCES 37
FIGURE 7 AI IN REMOTE PATIENT MONITORING MARKET: INSIGHTS FROM PRIMARIES 38
FIGURE 8 BREAKDOWN OF PRIMARY SOURCES: BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
FIGURE 10 AI IN REMOTE PATIENT MONITORING MARKET: SUPPLY-SIDE MARKET ESTIMATION 41
FIGURE 11 AI IN REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH FOR OMRON HEALTHCARE, INC. (2023) 42
FIGURE 12 BOTTOM-UP APPROACH: END-USER SPENDING ON AI-BASED REMOTE PATIENT MONITORING SOLUTIONS 43
FIGURE 13 AI IN REMOTE PATIENT MONITORING MARKET: TOP-DOWN APPROACH 44
FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 46
FIGURE 15 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
FIGURE 16 AI IN REMOTE PATIENT MONITORING MARKET: DATA TRIANGULATION 48
FIGURE 17 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024 VS. 2030 (USD MILLION) 51
FIGURE 18 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024 VS. 2030 (USD MILLION) 52
FIGURE 19 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 53
FIGURE 20 AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT 54
FIGURE 21 IMPROVED MEDICAL INFRASTRUCTURE AND COST BENEFITS OF REMOTE HEALTH MONITORING TO DRIVE MARKET 55
FIGURE 22 US AND HEALTHCARE PROVIDERS TO COMMAND LARGEST NORTH AMERICAN MARKET SHARE IN 2023 56
FIGURE 23 INDIA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 57
FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 57
FIGURE 25 AI IN REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
FIGURE 26 US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 64
FIGURE 27 AI IN REMOTE PATIENT MONITORING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 68
FIGURE 28 AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 70
FIGURE 29 AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 30 AVERAGE SELLING PRICE FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY TYPE (2023) 92
FIGURE 31 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 94
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP
THREE END USERS 96
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 97
FIGURE 34 PATENT PUBLICATION TRENDS IN AI IN REMOTE PATIENT MONITORING MARKET, 2015–2024 98
FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015–DECEMBER 2024) 98
FIGURE 36 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–DECEMBER 2024) 99
FIGURE 37 AI IN REMOTE PATIENT MONITORING MARKET: FUNDING AND NUMBER OF DEALS, 2022–2024 107
FIGURE 38 US: PERCENTAGE OF NEW CANCER CASES (2024) 123
FIGURE 39 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT 144
FIGURE 40 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT 176
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION) 216
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET (2023) 217
FIGURE 43 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 221
FIGURE 44 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT 222
FIGURE 45 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 228
FIGURE 46 EV/EBITDA OF KEY VENDORS 230
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 230
FIGURE 48 AI IN REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231
FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT 236
FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 241
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT 248
FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 252
FIGURE 53 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT 257
FIGURE 54 RESMED, INC.: COMPANY SNAPSHOT 262
FIGURE 55 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 268
FIGURE 56 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT 274
FIGURE 57 IRHYTHM INC.: COMPANY SNAPSHOT 277
FIGURE 58 MASIMO: COMPANY SNAPSHOT 290
FIGURE 59 DEXCOM, INC.: COMPANY SNAPSHOT 294
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
- 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
- オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
- 建設重機市場 – 2030年までの世界予測 2025-04-03
- 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02